Good morning :)
Switch to
Place Order

How to use scorecard? Learn more

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹268 cr, stock is ranked 1,643
High RiskStock is 3.28x as volatile as Nifty
104.753.72% (-4.05)
Scorecard

Performance

Low

Hasn't faired well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹268 cr, stock is ranked 1,643
High RiskStock is 3.28x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
-16.612.00
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
33.904.150.93%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+57.91+70.10+77.99+91.99-14.80-24.37-19.36-16.18
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnFeb 1, 2023

Brooks Laboratories Limited has informed the Exchange about Newspaper Publication | Download

Brooks Laboratories Limited has informed the Exchange about Newspaper Publication | Download

Shareholders meeting 
Announced OnJan 31, 2023

Brooks Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot | Download

Brooks Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot | Download

Outcome of Board Meeting 
Announced OnJan 27, 2023

Brooks Laboratories Limited has informed the Exchange with reference to disclosure made w.r.t Board meeting held on January 25, 2023. | Download

Brooks Laboratories Limited has informed the Exchange with reference to disclosure made w.r.t Board meeting held on January 25, 2023. | Download

See all events